Therapeutic Asset Ratings
1,133 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
sn301a
Hepatocellular Carcinoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Early P1
C
(36)
sph6516 tablets
Cancer
Shanghai Pharmaceuticals Holding Co., Ltd
Early P1
C
(36)
Sxrn
Cancer
Jiangsu Nutai Biologics Co., Ltd
Early P1
C
(36)
Syncar-100
B-Cell Acute Lymphoblastic Leukemia
Zhejiang University
Early P1
C
(36)
Targeted Aml1-Eto Neoantigen Cytotoxic T Cells
Acute Myeloid Leukemia
BGI, China
Early P1
C
(36)
TEONANACATL
Cognitive Disorder
Johns Hopkins University
Early P1
C
(36)
Terazosin
Amyotrophic Lateral Sclerosis
University of Iowa
Early P1
C
(36)
Tofacitinib
Amyotrophic Lateral Sclerosis
Beijing Tiantan Hospital
Early P1
C
(36)
Ttx-Mc138-Nodaga-Cu64
Cancer
TransCode Therapeutics
Early P1
C
(36)
Xentuzumab
Prostate Cancer
University of Oxford
Early P1
C
(36)
177Lu-P17-087
Metastatic Prostate Carcinoma
Peking Union Medical College Hospital
Early P1
C
(34)
177lu-p17-088
Metastatic Prostate Carcinoma
Peking Union Medical College Hospital
Early P1
C
(34)
177lu-rad204
Endometrial Carcinoma
Radiopharm Theranostics, Ltd
Early P1
C
(34)
177lu-rad204
Non-Small Cell Lung Carcinoma
Radiopharm Theranostics, Ltd
Early P1
C
(34)
18f-flt
Metastatic Prostate Carcinoma
University of Wisconsin, Madison
Early P1
C
(34)
[18F]MODAG-009
Parkinson Disease
MODAG GmbH
Early P1
C
(34)
64Cu-LLP2A
Follicular Lymphoma
Washington University School of Medicine
Early P1
C
(34)
68ga-ny104
Renal Cell Carcinoma
Affiliated Hospital of Jiangnan University
Early P1
C
(34)
89zr-dfo-n-suc-c9scfv
Glioblastoma
Var2 Pharmaceuticals
Early P1
C
(34)
89zr-dfo-n-suc-c9scfv
Head And Neck Squamous Cell Carcinoma
Var2 Pharmaceuticals
Early P1
C
(34)
89Zr-DFO-N-Suc-F8scFv
Glioblastoma
Var2 Pharmaceuticals
Early P1
C
(34)
89Zr-DFO-N-Suc-F8scFv
Head And Neck Squamous Cell Carcinoma
Var2 Pharmaceuticals
Early P1
C
(34)
ABO2109
Neoplasm
Suzhou Abogen Biosciences Co., Ltd.
Early P1
C
(34)
Acetadote
Glioblastoma
University of Texas Southwestern Medical Center
Early P1
C
(34)
Acetylsalicylic Acid
Fallopian Tube Cancer
H. Lee Moffitt Cancer Center and Research Institute
Early P1
C
(34)
Showing 801 to 825 of 1,133 assets
Previous
Page 33 of 46
Next